Bala Taila Matra Basti in the management of Mootraghata(Benign Prostatic Hyperplasia

Efficacy of Varunashigravadi Ghanavati with Bala Taila Matra Basti in the management of Mootraghata(Benign Prostatic Hyperplasia)- An open labelled randomized controlled clinical trial.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/030110

Enrollment

Registered

2020-12-29

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N400- Benign prostatic hyperplasia without lower urinary tract symptoms

Interventions

Intervention1: GROUP A: In group A patient was treated with varunashigravaadi Ghanavati 500 mg 2 vati TDS orally and Bala Tail Matra Basti 60 ml OD in a day for 1 month Control Intervention1: GROUP B:

Eligibility

Inclusion criteria

Inclusion criteria: The patients between 50-70 years of age The patients having 3 or more than 3 signs and symptoms of Mootraghata(Benign Prostatic Hyperplasia) Controlled Hypertension (BP less than 150-90 mmHg), diabetes mellitus (RBS less than 140 mg/dl)

Exclusion criteria

Exclusion criteria: Patients of age below 50 years and above 70 years Patients of malignancy, congenital deformities of urogenital tract or any abdominal-pelvic pathology other than BPH Systemic diseases like chronic renal failure (CRF), Uncontrolled Hypertension (BP >150-90), diabetes mellitus (RBS >140) Patients having Hematuria(Blood in the urine) , Bladder infection(UTI), kidney stone, Bladder stone PSA level above 4.0 ng/ml Patients k/c/o Tuberculosis, Paralysis, and Parkinsonism will be excluded Known case of cardiac diseases (H/o- MI, IHD)

Design outcomes

Primary

Measure	Time frame
Prostate size reduced decrease in PSA levelTimepoint: 4 weeks	—

Secondary

Measure	Time frame
Improvement in sign and symptoms of BPH and also improvement in quality of lifeTimepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDr T S Dudhamal

Institute for Post Graduate Teaching and Research in Ayurveda GAU

ajtalsaniya32@gmail.com7984969783

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026